For: | Suri A, Jagadish N, Saini S, Gupta N. Targeting cancer testis antigens for biomarkers and immunotherapy in colorectal cancer: Current status and challenges. World J Gastrointest Oncol 2015; 7(12): 492-502 [PMID: 26691579 DOI: 10.4251/wjgo.v7.i12.492] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v7/i12/492.htm |
Number | Citing Articles |
1 |
Markus D. Lacher, Gerhard Bauer, Brian Fury, Sanne Graeve, Emily L. Fledderman, Tye D. Petrie, Dane P. Coleal-Bergum, Tia Hackett, Nicholas H. Perotti, Ying Y. Kong, William W. Kwok, Joseph P. Wagner, Charles L. Wiseman, William V. Williams. SV-BR-1-GM, a Clinically Effective GM-CSF-Secreting Breast Cancer Cell Line, Expresses an Immune Signature and Directly Activates CD4+ T Lymphocytes. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.00776
|
2 |
Olga Gordeeva. Cancer-testis antigens: Unique cancer stem cell biomarkers and targets for cancer therapy. Seminars in Cancer Biology 2018; 53: 75 doi: 10.1016/j.semcancer.2018.08.006
|
3 |
Alaa Alsalloum, Julia Shevchenko, Sergey Sennikov. The Melanoma-Associated Antigen Family A (MAGE-A): A Promising Target for Cancer Immunotherapy?. Cancers 2023; 15(6): 1779 doi: 10.3390/cancers15061779
|
4 |
Rui Bai, Cheng Yuan. Kita-Kyushu Lung Cancer Antigen-1 (KK-LC-1): A Promising Cancer Testis Antigen. Aging and disease 2022; 13(4): 1267 doi: 10.14336/AD.2021.1207
|
5 |
Guangyuan Li, Daniel Schnell, Anukana Bhattacharjee, Mark Yarmarkovich, Nathan Salomonis. Quantifying tumor specificity using Bayesian probabilistic modeling for drug and immunotherapeutic target discovery. Cell Reports Methods 2024; 4(11): 100900 doi: 10.1016/j.crmeth.2024.100900
|
6 |
Ye-Rin Kim, Myung-Ha Song, Jun-Won Lee, Jae-Ho Bae, Jong-Eun Kim, Dong-Muk Kang, Sang-Yull Lee. Identification of tumor antigens in malignant mesothelioma. Oncology Letters 2017; 14(4): 4557 doi: 10.3892/ol.2017.6805
|
7 |
Zhongen Wu, Mengxuan Yang, Yiou Cao. Tumor antigens and vaccines in colorectal cancer. Medicine in Drug Discovery 2022; 16: 100144 doi: 10.1016/j.medidd.2022.100144
|
8 |
Ragaa A Ramadan, Heba Morsy, Mohamed Samir, Mohamed Shamseya, Maha Shalaby, Eman A El-Attar. Significance of cancer testis-associated antigens (SPAG9 and FBXO39) in colon cancer. Indian Journal of Cancer 2022; 59(3): 394 doi: 10.4103/ijc.IJC_873_19
|
9 |
Erik Schooten, Alessia Di Maggio, Paul M.P. van Bergen en Henegouwen, Marta M. Kijanka. MAGE-A antigens as targets for cancer immunotherapy. Cancer Treatment Reviews 2018; 67: 54 doi: 10.1016/j.ctrv.2018.04.009
|
10 |
Mikhlid H. Almutairi, Mona M. Alotaibi, Rasha Alonaizan, Bader O. Almutairi, Hafiz Ishfaq Ahmad. [Retracted] Expression Profile of MAGE‐B1 Gene and Its Hypomethylation Activation in Colon Cancer. BioMed Research International 2022; 2022(1) doi: 10.1155/2022/6066567
|
11 |
Ping Yang, Mei Meng, Quansheng Zhou. Oncogenic cancer/testis antigens are a hallmarker of cancer and a sensible target for cancer immunotherapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2021; 1876(1): 188558 doi: 10.1016/j.bbcan.2021.188558
|
12 |
Mei Feng, Zhongwei Zhao, Mengxuan Yang, Jiansong Ji, Di Zhu. T-cell-based immunotherapy in colorectal cancer. Cancer Letters 2021; 498: 201 doi: 10.1016/j.canlet.2020.10.040
|
13 |
Ana Roguljic, Gulio Spagnoli, Antonio Juretic, Bozena Sarcevic, Marija Banovic, Lidija Beketic Oreskovic. Possible predictive role of cancer/testis antigens in breast ductal carcinoma in�situ. Oncology Letters 2018; doi: 10.3892/ol.2018.9544
|
14 |
Mikhlid H. Almutairi, Turki M. Alrubie, Abdullah M. Alamri, Bader O. Almutairi, Abdulwahed F. Alrefaei, Maha M. Arafah, Mohammad Alanazi, Abdelhabib Semlali. Cancer-Testis Gene Biomarkers Discovered in Colon Cancer Patients. Genes 2022; 13(5): 807 doi: 10.3390/genes13050807
|